Microbot Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.15	3.91	3.11	2.47	2.44	13.49
Short-Term Investments	64.22	74.68	2.36	3.92	5.76	2
Cash & Short-Term Investments	67.37	78.59	5.47	6.39	8.21	15.49
Cash Growth	106.18%	1336.78%	-14.33%	-22.18%	-47.04%	-37.15%
Accounts Receivable	0.18	-	-	-	-	-
Other Receivables	-	-	-	1.34	-	-
Total Trade Receivables	0.18	-	-	1.34	-	-
Inventory	2.91	0.58	-	-	-	-
Other Current Assets	1.72	0.65	0.35	0.2	0.61	0.39
Total Current Assets	72.17	79.82	5.82	7.92	8.81	15.88
Net Property, Plant & Equipment	1.12	0.93	0.21	0.41	0.72	0.89
Other Long-Term Assets	0.08	0.8	-	-	-	-
Total Assets	73.37	81.54	6.03	8.33	9.54	16.77
Accounts Payable	0.87	0.51	0.17	0.36	0.12	0.28
Accrued Expenses	2.69	2.61	2.23	3.24	1.67	1.43
Current Portion of Leases	0.33	0.3	0.07	0.19	0.28	0.28
Total Current Liabilities	3.89	3.42	2.46	3.79	2.07	1.98
Long-Term Leases	0.55	0.57	0.04	0.04	0.18	0.4
Total Long-Term Liabilities	0.55	0.57	0.04	0.04	0.18	0.4
Total Liabilities	4.44	3.99	2.5	3.83	2.25	2.39
Common Stock	0.67	0.67	0.2	0.12	0.08	0.07
Additional Paid-in Capital	181.64	180.97	94.28	83.88	75.97	69.9
Retained Earnings	-113.38	-104.09	-90.94	-79.5	-68.76	-55.59
Shareholders' Equity	68.93	77.55	3.53	4.5	7.29	14.38
Total Liabilities & Equity	73.37	81.54	6.03	8.33	9.54	16.77
Total Debt	0.88	0.87	0.11	0.23	0.46	0.68
Net Cash (Debt)	66.49	77.73	5.36	6.15	7.74	14.81
Net Cash Growth	104.43%	1350.40%	-12.92%	-20.52%	-47.73%	-37.86%
Net Cash Per Share	0.99	1.16	0.28	0.53	0.98	2.08
Book Value	68.93	77.55	3.53	4.5	7.29	14.38
Book Value Per Share	1.03	1.15	0.18	0.38	0.92	2.02
Tangible Book Value	68.93	77.55	3.53	4.5	7.29	14.38
Tangible Book Value Per Share	1.03	1.15	0.18	0.38	0.92	2.02

SEC Filings: 10-K · 10-Q